VERACYTE INC.

Veracyte, Inc. specializes in advanced molecular diagnostic services and reference laboratory solutions, primarily delivering genomic testing and precision diagnostics for clinical decision support. Their core capabilities include the deployment of next-generation sequencing platforms, such as the Afirma Genomic Sequencing Classifier, and targeted molecular assays for thyroid and other endocrine disorders. The company provides high-complexity clinical laboratory services with a focus on diagnostic accuracy, algorithm-driven classification, and scalable reference lab infrastructure tailored to large-scale healthcare systems. Their technical expertise lies in genomic data interpretation, liquid biopsy analysis, and FDA-cleared diagnostic tools that reduce unnecessary surgeries and improve patient outcomes in oncology and endocrinology. Veracyte maintains a strong, sustained relationship with the Department of Veterans Affairs, consistently supporting VA medical centers through reference laboratory services and task-order-based genomic testing programs. Their work for the VA centers on delivering specialized diagnostic solutions across VISN networks, enabling standardized, high-quality testing for veterans in remote and urban facilities alike. The Department of Defense is also represented in their contract history, indicating capacity to meet federal defense healthcare requirements for advanced diagnostics. The company’s primary industry focus is medical laboratories under NAICS 621511, where they operate as a niche provider of genomic and molecular diagnostics within government healthcare delivery systems. They are positioned at the intersection of precision medicine and public health infrastructure, serving as a trusted partner for complex, evidence-based testing that informs clinical pathways. Veracyte, Inc. is a limited liability entity headquartered in South San Francisco, California, with a dedicated laboratory and research infrastructure supporting federal contract obligations. While no formal government certifications are listed, their operational model reflects adherence to CLIA, CAP, and HIPAA standards required for federal clinical lab services. Their geographic presence and technical specialization make them a key provider for federal agencies requiring advanced diagnostic capabilities.